MICROBOT MEDICAL INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
MICROBOT MEDICAL INC. (MBOT) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $495.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-03-26
- MICROBOT MEDICAL INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2016-09-30 was -$2.90M, a 382.50% decline year-over-year.
- MICROBOT MEDICAL INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2016-06-30 was $121.74K, a 28.88% increase year-over-year.
- MICROBOT MEDICAL INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2016-03-31 was -$1.57M.
- MICROBOT MEDICAL INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2015-12-31 was $803.38K, a 72.92% decline year-over-year.
- MICROBOT MEDICAL INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $495.00K, a 43.30% decline from fiscal 2024.
- MICROBOT MEDICAL INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $873.00K.
- MICROBOT MEDICAL INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2015 was $292.19K, a 85.78% decline from fiscal 2014.
- MICROBOT MEDICAL INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2014 was $2.06M, a 4.13% decline from fiscal 2013.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2025-12-31 | $495.00K 10-K · filed 2026-03-26 | |||
| 2024-12-31 | $873.00K 10-K · filed 2026-03-26 | |||
| 2016-09-30 | -$2.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$2.77M derived: sum of 2 quarters · filed 2016-11-03 | -$4.35M 10-Q · filed 2016-11-03 | -$3.54M derived: sum of 4 quarters · filed 2016-11-03 |
| 2016-06-30 | $121.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | -$1.45M 10-Q · filed 2016-08-15 | -$646.27K derived: sum of 3 quarters · filed 2016-08-15 | $378.74K derived: sum of 4 quarters · filed 2016-11-03 |
| 2016-03-31 | -$1.57M 10-Q · filed 2016-05-10 | -$768.01K derived: sum of 2 quarters · filed 2016-05-10 | $256.99K derived: sum of 3 quarters · filed 2016-11-03 | $351.46K derived: sum of 4 quarters · filed 2016-11-03 |
| 2015-12-31 | $803.38K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $1.83M derived: sum of 2 quarters · filed 2016-11-03 | $1.92M derived: sum of 3 quarters · filed 2016-11-03 | $292.19K 10-K · filed 2016-03-15 |
| 2015-09-30 | $1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $1.12M derived: sum of 2 quarters · filed 2016-11-03 | -$511.19K 10-Q · filed 2016-11-03 | $2.46M derived: sum of 4 quarters · filed 2016-11-03 |
| 2015-06-30 | $94.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | -$1.54M 10-Q · filed 2016-08-15 | $1.43M derived: sum of 3 quarters · filed 2016-08-15 | $1.10M derived: sum of 4 quarters · filed 2016-08-15 |
| 2015-03-31 | -$1.63M 10-Q · filed 2016-05-10 | $1.34M derived: sum of 2 quarters · filed 2016-05-10 | $1.01M derived: sum of 3 quarters · filed 2016-05-10 | $1.06M derived: sum of 4 quarters · filed 2016-05-10 |
| 2014-12-31 | $2.97M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $2.64M derived: sum of 2 quarters · filed 2016-03-15 | $2.69M derived: sum of 3 quarters · filed 2016-03-15 | $2.06M 10-K · filed 2016-03-15 |
| 2014-09-30 | -$327.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | -$274.14K derived: sum of 2 quarters · filed 2015-11-02 | -$911.33K 10-Q · filed 2015-11-02 | $732.65K derived: sum of 4 quarters · filed 2016-03-15 |
| 2014-06-30 | $53.76K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$583.43K 10-Q · filed 2015-08-06 | $1.06M derived: sum of 3 quarters · filed 2016-03-15 | $267.89K derived: sum of 4 quarters · filed 2016-03-15 |
| 2014-03-31 | -$637.19K 10-Q · filed 2015-05-05 | $1.01M derived: sum of 2 quarters · filed 2016-03-15 | $214.13K derived: sum of 3 quarters · filed 2016-03-15 | $2.30M derived: sum of 4 quarters · filed 2016-03-15 |
| 2013-12-31 | $1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $851.32K derived: sum of 2 quarters · filed 2016-03-15 | $2.94M derived: sum of 3 quarters · filed 2016-03-15 | $2.14M 10-K · filed 2016-03-15 |
| 2013-09-30 | -$792.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $1.30M derived: sum of 2 quarters · filed 2014-11-13 | $499.94K 10-Q · filed 2014-11-13 | $1.70M derived: sum of 4 quarters · filed 2015-03-13 |
| 2013-06-30 | $2.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $1.29M 10-Q · filed 2014-08-12 | $2.50M derived: sum of 3 quarters · filed 2015-03-13 | $2.40M derived: sum of 4 quarters · filed 2015-03-13 |
| 2013-03-31 | -$798.21K 10-Q · filed 2014-05-14 | $405.58K derived: sum of 2 quarters · filed 2015-03-13 | $313.32K derived: sum of 3 quarters · filed 2015-03-13 | -$43.60K derived: sum of 4 quarters · filed 2015-03-13 |
| 2012-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $1.11M derived: sum of 2 quarters · filed 2015-03-13 | $754.62K derived: sum of 3 quarters · filed 2015-03-13 | -$409.33K 10-K · filed 2015-03-13 |
| 2012-09-30 | -$92.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | -$449.17K derived: sum of 2 quarters · filed 2013-11-05 | -$1.61M 10-Q · filed 2013-11-05 | -$1.34M derived: sum of 4 quarters · filed 2014-03-13 |
| 2012-06-30 | -$356.91K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | -$1.52M 10-Q · filed 2013-08-07 | -$1.25M derived: sum of 3 quarters · filed 2014-03-13 | -$493.71K derived: sum of 4 quarters · filed 2014-03-13 |
| 2012-03-31 | -$1.16M 10-Q · filed 2013-05-10 | -$891.06K derived: sum of 2 quarters · filed 2014-03-13 | -$136.80K derived: sum of 3 quarters · filed 2014-03-13 | $150.46K derived: sum of 4 quarters · filed 2014-03-13 |
| 2011-12-31 | $272.89K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $1.03M derived: sum of 2 quarters · filed 2014-03-13 | $1.31M derived: sum of 3 quarters · filed 2014-03-13 | $130.77K 10-K · filed 2014-03-13 |
| 2011-09-30 | $754.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $1.04M derived: sum of 2 quarters · filed 2012-11-08 | -$142.12K 10-Q · filed 2012-11-08 | $755.85K derived: sum of 4 quarters · filed 2013-03-21 |
| 2011-06-30 | $287.26K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | -$896.38K 10-Q · filed 2012-08-08 | $1.58K derived: sum of 3 quarters · filed 2013-03-21 | -$68.44K derived: sum of 4 quarters · filed 2013-03-21 |
| 2011-03-31 | -$1.18M 10-Q · filed 2012-05-10 | -$285.68K derived: sum of 2 quarters · filed 2013-03-21 | -$355.71K derived: sum of 3 quarters · filed 2013-03-21 | |
| 2010-12-31 | $897.97K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-21 | $827.94K derived: sum of 2 quarters · filed 2013-03-21 | -$808.72K 10-K · filed 2013-03-21 | |
| 2010-09-30 | -$70.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | -$1.71M 10-Q · filed 2011-11-03 | ||
| 2010-06-30 | -$1.64M 10-Q · filed 2011-08-05 | |||
| 2009-12-31 | $477.17K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B |